benralizumab (102)

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

EVQLVQSGAE VKKPGASVKV SCKASGYTFT SYVIHWVRQR PGQGLAWMGY  50

INPYNDGTKY NERFKGKVTI TSDRSTSTVY MELSSLRSED TAVYLCGREG 100

IRYYGLLGDY WGQGTLVTVS SASTKGPSVF PLAPSSKSTS GGTAALGCLV 150

KDYFPEPVTV SWNSGALTSG VHTFPAVLQS SGLYSLSSVV TVPSSSLGTQ 200

TYICNVNHKP SNTKVDKKVE PKSCDKTHTC PPCPAPELLG GPSVFLFPPK 250

PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY 300

NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP 350

QVYTLPPSRD ELTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP 400

VLDSDGSFFL YSKLTVDKSR WQQGNVFSCS VMHEALHNHY TQKSLSLSPG 450

K                                                      451

Light chain / Chaone lygire / Cadena ligera

DIQMTQSPSS LSASVGDRVT ITCGTSEDII NYLNWYQQKP GKAPKLLIYH  50

TSRLQSGVPS RFSGSGSGTD FTLTISSLQP EDFATYYCQQ GYTLPYTFGQ 100

GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV 150

DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG 200

LSSPVTKSFN RGEC                                        214

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-96	148-204	265-325	371-429

	22??-96??	148??-204??	265??-325??	371??-429??

Intra-L	23?-88?	134?-194?



	23???-88???	134???-194???



Inter-H-L	224-214?	224??-214???



Inter-H-H	230-230??	233-233??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

301, 301??

CAS		1044511-01-4

Description

immunoglobulin G1-kappa, anti-[Homo sapiens IL5RA (interleukin 5
receptor subunit alpha, CD125)], humanized monoclonal antibody;

gamma1 heavy chain (1-451) [humanized VH (Homo sapiens IGHV1-46*01
(78.60%) -(IGHD)-IGHJ4*01) [8.8.14] (1-121) -Homo sapiens IGHG1*01
(122-451)], (224-214?)-disulfide with kappa light chain (1'-214')
[humanized V-KAPPA (Homo sapiens IGKV1-39*01 (87.40%) -IGKJ2*01) [6.3.9]
(1?-107?) -Homo sapiens IGKC*01 (108?-214?)];
(230-230":233-233")-bisdisulfide dimer 

immunoglobuline G1-kappa, anti-[Homo sapiens ILR5A (sous-unity alpha du
rycepteur de l'interleukine 5, CD125)], anticorps monoclonal humanisy; 

chaone lourde gamma1 (1-451) [VH humanisy (Homo sapiens IGHV1-46*01
(78.60%) -(IGHD)-IGHJ4*01) [8.8.14] (1-121) -Homo sapiens IGHG1*01
(122-451)], (224-214?)-disulfure avec la chaone lygire kappa (1'-214')
[V-KAPPA humanisy (Homo sapiens IGKV1-39*01 (87.40%) -IGKJ2*01) [6.3.9]
(1?-107?) -Homo sapiens IGKC*01 (108?-214?)]; dimire
(230-230":233-233")-bisdisulfure 

inmunoglobulina G1-kappa, anti-[Homo sapiens ILR5A (subunidad alfa del
receptor de la interleukina 5, CD125)], anticuerpo monoclonal
humanizado; 

cadena pesada gamma1 (1-451) [VH humanizada (Homo sapiens IGHV1-46*01
(78.60%) -(IGHD)-IGHJ4*01) [8.8.14] (1-121) -Homo sapiens IGHG1*01
(122-451)], (224-214?)-disulfuro con la cadena ligera kappa (1?-214?)
[V-KAPPA humanizada (Homo sapiens IGKV1-39*01 (87.40%) -IGKJ2*01)
[6.3.9] (1?-107?) -Homo sapiens IGKC*01 (108?-214?)]; dnmero
(230-230":233-233")-bisdisulfuro 

	

WHO 

International Nonproprietary Names Programme	

15/01/2010

9233



		

